Will the FDA approve camizestrant for advanced breast cancer?
Will the FDA approve camizestrant for advanced breast cancer? Live odds across 4 markets: Before Jan 1, 2028 at 77¢. Resolves Jan 1, 2028. Not financial advice.
Resolves Jan 1, 2028
- Before Jul 1, 2026: Yes 14¢ (kalshi)
- Before Oct 1, 2026: Yes 39¢ (kalshi)
- Before Jan 1, 2027: Yes 65¢ (kalshi)
- Before Jan 1, 2028: Yes 77¢ (kalshi)
LIVE
8sWill the FDA approve camizestrant for advanced breast cancer?
Resolves Jan 1, 2028
Total Volume
$2.7K
+$4 (24h)
Active Markets
4
Across 1 platforms
Frontrunner
74¢
Before Jan 1, 2028
Biggest Mover 24h
-3¢
Before Jul 1, 2026
Arb Opportunities
0
None detected
All Markets
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 74¢ | 77¢ | $79 | -3¢ | — | |
| 2 | 63¢ | 65¢ | $91 | -2¢ | — | |
| 3 | 37¢ | 39¢ | $721 | -2¢ | — | |
| 4 | 13¢ | 14¢ | $1.8K+$4 24h | -3¢ | — |
Implied Probability
Consensus across platformsPrice History
Event Info
Whale Activity
Loading...